Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Motor Activity 6Polycystic Ovary Syndrome 2Obesity 2Diabetes Mellitus 2Stroke 1Sedentary Behavior 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Kidney Diseases 1Insulin Resistance 1Hypertension 1Heart Failure 1Frailty 1Endometrial Neoplasms 1Diabetes Mellitus, Type 2 1Cardiovascular Diseases 1Breast Neoplasms 1Body Weight 1Arthritis 1

Interventions

Cytarabine 167fludarabine phosphate 102Cyclophosphamide 97Azacitidine 92Whole-Body Irradiation 78fludarabine 77Mycophenolic Acid 71Busulfan 68Tacrolimus 59Peripheral Blood Stem Cell Transplantation 55Decitabine 55Granulocyte Colony-Stimulating Factor 49Filgrastim 44Daunorubicin 44Cyclosporine 42Methotrexate 41Melphalan 41Etoposide 41Clofarabine 41Idarubicin 39Mitoxantrone 34Antilymphocyte Serum 34venetoclax 32thymoglobulin 23Thiotepa 23Stem Cell Transplantation 21Injections 16Gemtuzumab 16CPX-351 16Sirolimus 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Acute × Resistance Training × Clear all
NCT01170598 2012-04-20

Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy

Toronto Rehabilitation Institute

Phase 2 Completed
35 enrolled 15 charts
Other hematologic neoplasm

Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡